AstraZeneca stock jumps after surprise lung disease trial win
AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its…
Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
Novartis, Roche could be most at risk
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…
Roche, Sanofi tout pharma pipelines as earnings fail to excite
Drugmakers Roche and Sanofi’s latest earnings were largely as expected, with the companies talking up the potential of…